Výsledky vyhledávání - "Pooja Manroa"

The Clinical Utility of Molecular Testing in the Management of Thyroid Follicular Neoplasms (Bethesda IV Nodules)

Autor: Kelly L. McCoy, N. Paul Ohori, Pooja Manroa, Shaum Sridharan, Sally E. Carty, Raja R. Seethala, Dane A Hilko, Elena M. Morariu, Esra Karslioglu French, Linwah Yip

Publikováno v: Annals of Surgery. 272:621-627

FN present a management quandary as they are often benign but may also be aggressive TC. Consensus recommendations have historically advised thyroidectomy for definitive diagnosis. Although MT have robust benefit in hypothetical cost analyses, under

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5757d60bd6eee3901696d8f0cb23cade
https://doi.org/10.1097/sla.0000000000004130

Zobrazit plný text záznamu

Addressing Pitfalls in Management of Diabetic Ketoacidosis with a Standardized Protocol

Autor: Jodie Reider, Runa Acharya, Rose A. Salata, Ronald A. Codario, Neha D. Karajgikar, Mary T. Korytkowski, Amy C. Donihi, Pooja Manroa

Publikováno v: Endocrine Practice. 25:407-412

Objective: To determine the efficacy and safety of a diabetic ketoacidosis (DKA)-Power Plan (PP) for guiding intravenous (IV) insulin infusions prior to anion gap (AG) closure and administering subcutaneous (SC) insulin ≥1 hour before discontinuing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836cb95c69389d66adbac0b286aba104
https://doi.org/10.4158/ep-2018-0398

Zobrazit plný text záznamu

Clinicopathologic Characteristics of Thyroid Nodules Positive for the THADA-IGF2BP3 Fusion on Preoperative Molecular Analysis

Autor: Kelly L. McCoy, Simion I. Chiosea, Pooja Manroa, Marina N. Nikiforova, Yuri E. Nikiforov, Elena M. Morariu, Alyaksandr V. Nikitski

Publikováno v: Thyroid.

Background: Thyroid adenoma-associated (THADA)-IGF2BP3 fusions have been identified as an oncogenic event in thyroid neoplasms. However, the prevalence of this gene fusion and associated phenotypic...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::049d2eb1194579ca3ac0dd74897eb2b0
https://doi.org/10.1089/thy.2020.0589

Zobrazit plný text záznamu

Molecular alterations in Hürthle cell nodules and preoperative cancer risk

Autor: Simion I. Chiosea, William R Doerfler, Michael S. Landau, Linwah Yip, Alyaksandr V. Nikitski, N. Paul Ohori, Pooja Manroa, Elena M. Morariu, Marina N. Nikiforova, Yuri E. Nikiforov

Publikováno v: Endocrine-related cancer. 28(5)

Hürthle cell carcinoma (HCC) is a distinct type of thyroid cancer genetically characterized by DNA copy number alterations (CNA), typically of genome haploidization type (GH-type). However, whether CNA also occurs in benign Hürthle cell adenomas (H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a3990f9e4b0fdcc96b4bcaeb4419609
https://pubmed.ncbi.nlm.nih.gov/33792557

Zobrazit plný text záznamu

OR21-02 Impact of Nodule Size on the Probability of Hurthle Cell Carcinoma and Other Cancers in Thyroid Nodules with Multiple Chromosomal Copy Number Alterations

Autor: Lindsey A. Tolino, Jessica C. Tebbets, Alyaksandr V. Nikitski, Linwah Yip, Pooja Manroa, Marina N. Nikiforova, Yuri E. Nikiforov

Publikováno v: Journal of the Endocrine Society

Fine-needle aspiration (FNA) of thyroid nodules yields indeterminate cytological diagnosis in ~20% of cases, confounding patient management. This includes Hurthle cell nodules, which typically yield Bethesda IV and III cytology. Chromosomal copy numb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc92556bed2c947732d68adc1a76b881
https://doi.org/10.1210/jendso/bvaa046.1766

Zobrazit plný text záznamu

Benign call rate and molecular test result distribution of ThyroSeq v3

Autor: Pooja Manroa, N. Paul Ohori, Shane O. LeBeau, Marina N. Nikiforova, Yuri E. Nikiforov, Raja R. Seethala, Michael S. Landau, Sally E. Carty, Karen E. Schoedel, Linwah Yip

Publikováno v: Cancer Cytopathology. 127:161-168

Background The benign call rate (BCR) is the percentage of cytomorphologically indeterminate cases with subsequent benign or negative molecular results. For rule-out tests, the BCR is an important parameter because these molecular "negative" cases ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82a28517335faf59b07d9d0c7b8d241
https://doi.org/10.1002/cncy.22088

Zobrazit plný text záznamu

Self-monitoring of blood glucose: Advice for providers and patients

Autor: Krupa Doshi, Shannon Knapp, Pooja Manroa

Publikováno v: Cleveland Clinic Journal of Medicine. 83:355-360

Self-monitoring of blood glucose is a critical element in diabetes management. Providers must determine if and when patients are to perform glucose self-monitoring, set blood glucose targets, and help patients to interpret the results. Patients have

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05d3d81802b510c659e17690bed08eef
https://doi.org/10.3949/ccjm.83a.14147

Zobrazit plný text záznamu

Risk Factors for Hospital Readmission following Implementation of a Diabetic Ketoacidosis (DKA) Power Plan

Autor: Amy C Donihi, Pooja Manroa, Rose A. Salata, Ronald Codario, Neha Karajgikar, Runa Acharya, Mary T. Korytkowski

Publikováno v: Diabetes. 67

Patients admitted to the hospital with DKA are at high-risk for readmission. We have previously demonstrated that implementation of a DKA PowerPlan (PP) that guides IV insulin dosing following acute management and transition to SC insulin reduces the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e64069b26df8dcd50ac77b091f5e2066
https://doi.org/10.2337/db18-1279-p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání